See more : Noble Corporation Plc (NOBLE.CO) Income Statement Analysis – Financial Results
Complete financial analysis of ALPEK, S.A.B. de C.V. (ALPKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ALPEK, S.A.B. de C.V., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- London Security plc (LSC.L) Income Statement Analysis – Financial Results
- Cera Sanitaryware Limited (CERA.BO) Income Statement Analysis – Financial Results
- DV Biomed Co., Ltd. (6539.TWO) Income Statement Analysis – Financial Results
- PharmaCyte Biotech, Inc. (PMCB) Income Statement Analysis – Financial Results
- Tritax EuroBox plc (BOXE.L) Income Statement Analysis – Financial Results
ALPEK, S.A.B. de C.V. (ALPKF)
About ALPEK, S.A.B. de C.V.
Alpek, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico, the United States, Canada, the United Kingdom, Argentina, Brazil, and Chile. It operates in two segments, Polyester, and Plastics and Chemicals. The Polyester segment produces purified terephthalic acid for use as a raw material in polyethylene terephthalate (PET) and polyester fibers; PET, a plastic resin for use in the beverage bottles, food containers, and consumer good packaging applications; and recycled PET for use in new bottles and containers, strapping and packing supplies, and fibers for clothing and carpet. This segment also offers polyester fibers, such as staple fiber for use in carpets, garments, and home furnishings; and filament for clothing, automotive interiors, and seatbelts, as well as canvases, conveyor belts, hoses, and other industrial uses. The Plastics and Chemicals segment manufactures polypropylene, expandable polystyrene, caprolactam, and other chemicals, as well as specialty and industrial chemicals for use in the consumer goods, food and beverage packaging, automotive, construction, agriculture, oil, and pharmaceutical industries. The company was founded in 1975 and is based in San Pedro Garza García, Mexico. Alpek, S.A.B. de C.V. is a subsidiary of Alfa, S. A. B. de C. V.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138.16B | 212.44B | 156.22B | 113.99B | 119.69B | 134.52B | 99.00B | 90.19B | 83.59B | 86.07B | 90.06B | 96.16B | 90.67B | 61.15B | 53.57B |
| Cost of Revenue | 127.86B | 181.40B | 131.54B | 102.28B | 106.67B | 116.52B | 88.60B | 76.94B | 73.03B | 79.76B | 82.44B | 86.77B | 80.53B | 54.77B | 47.75B |
| Gross Profit | 10.30B | 31.03B | 24.69B | 11.71B | 13.02B | 18.00B | 10.40B | 13.25B | 10.56B | 6.31B | 7.62B | 9.40B | 10.14B | 6.38B | 5.82B |
| Gross Profit Ratio | 7.45% | 14.61% | 15.80% | 10.27% | 10.88% | 13.38% | 10.51% | 14.69% | 12.63% | 7.34% | 8.47% | 9.77% | 11.18% | 10.43% | 10.87% |
| Research & Development | 0.00 | 68.00M | 67.00M | 74.00M | 40.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.72B | 3.80B | 3.47B | 3.26B | 2.83B | 3.17B | 2.08B | 2.04B | 1.84B | 1.33B | 1.09B | 1.16B | 2.09B | 1.61B | 1.57B |
| Selling & Marketing | 2.13B | 3.14B | 2.57B | 2.14B | 2.09B | 2.14B | 1.75B | 1.58B | 1.38B | 1.22B | 1.08B | 1.07B | 0.00 | 0.00 | 0.00 |
| SG&A | 5.85B | 6.94B | 6.04B | 5.40B | 4.92B | 5.30B | 3.83B | 3.62B | 3.22B | 2.54B | 2.17B | 2.23B | 2.09B | 1.61B | 1.57B |
| Other Expenses | 10.88B | 269.00M | 274.00M | 451.00M | 659.00M | 423.00M | 97.00M | 90.00M | -8.72M | 114.92M | 14.58M | 146.64M | -660.00M | 109.00M | -281.00M |
| Operating Expenses | 16.73B | 6.94B | 6.04B | 5.40B | 4.92B | 5.30B | 3.83B | 3.62B | 3.21B | 2.54B | 2.17B | 2.21B | 2.09B | 1.61B | 1.57B |
| Cost & Expenses | 144.60B | 188.34B | 137.57B | 107.68B | 111.59B | 121.82B | 92.43B | 80.56B | 76.24B | 82.30B | 84.61B | 88.98B | 82.62B | 56.38B | 49.32B |
| Interest Income | 749.00M | 297.00M | 166.00M | 133.00M | 178.00M | 125.00M | 92.00M | 194.00M | 229.22M | 133.11M | 132.56M | 182.72M | -42.74M | 0.00 | 0.00 |
| Interest Expense | 2.40B | 2.04B | 2.61B | 2.01B | 2.36B | 1.88B | 1.28B | 1.11B | 946.64M | 803.39M | 987.97M | 1.57B | 1.06B | 0.00 | 0.00 |
| Depreciation & Amortization | 4.62B | 4.64B | 4.28B | 4.49B | 4.01B | 2.89B | 2.64B | 2.56B | 2.25B | 1.84B | 2.02B | 2.13B | -3.00M | 395.00M | 721.00M |
| EBITDA | -2.29B | 28.15B | 22.63B | 11.82B | 15.78B | 15.08B | -2.36B | 11.03B | 8.91B | 4.84B | 4.74B | 9.59B | 9.25B | 4.77B | 4.26B |
| EBITDA Ratio | -1.65% | 13.17% | 14.48% | 9.73% | 10.17% | 11.21% | 8.96% | 12.06% | 10.14% | 5.89% | 8.16% | 9.97% | 8.87% | 8.44% | 9.29% |
| Operating Income | -6.44B | 24.54B | 17.49B | 7.49B | 12.36B | 12.19B | -2.85B | 9.86B | 7.59B | 3.74B | 2.93B | 7.48B | 8.05B | 4.77B | 4.26B |
| Operating Income Ratio | -4.66% | 11.55% | 11.20% | 6.57% | 10.33% | 9.06% | -2.88% | 10.94% | 9.08% | 4.34% | 3.25% | 7.77% | 8.87% | 7.80% | 7.95% |
| Total Other Income/Expenses | -2.87B | -3.06B | -3.18B | -2.17B | -2.95B | -2.81B | -3.41B | -2.51B | -1.89B | -1.54B | -1.20B | -1.37B | -1.67B | -1.05B | -1.84B |
| Income Before Tax | -9.31B | 21.48B | 14.31B | 5.32B | 9.41B | 18.39B | -6.27B | 7.35B | 5.70B | 2.20B | 1.72B | 6.11B | 6.26B | 3.72B | 2.42B |
| Income Before Tax Ratio | -6.74% | 10.11% | 9.16% | 4.67% | 7.86% | 13.67% | -6.33% | 8.15% | 6.82% | 2.55% | 1.91% | 6.35% | 6.91% | 6.09% | 4.52% |
| Income Tax Expense | 727.00M | 5.51B | 4.12B | 1.20B | 1.89B | 3.46B | -1.71B | 2.36B | 2.04B | 883.03M | 817.33M | 1.72B | 1.97B | 1.16B | 885.00M |
| Net Income | -10.91B | 13.74B | 7.76B | 3.12B | 6.61B | 13.63B | -5.49B | 3.63B | 2.75B | 800.90M | 261.79M | 3.66B | 4.29B | 2.56B | 1.54B |
| Net Income Ratio | -7.90% | 6.47% | 4.96% | 2.74% | 5.52% | 10.13% | -5.54% | 4.02% | 3.29% | 0.93% | 0.29% | 3.81% | 4.73% | 4.19% | 2.87% |
| EPS | -5.18 | 6.52 | 3.67 | 1.48 | 3.12 | 6.44 | -2.59 | 1.71 | 1.30 | 0.38 | 0.12 | 1.83 | 2.24 | 1.47 | 0.88 |
| EPS Diluted | -5.18 | 6.52 | 3.67 | 1.48 | 3.12 | 6.44 | -2.59 | 1.71 | 1.30 | 0.38 | 0.12 | 1.83 | 2.24 | 1.21 | 0.73 |
| Weighted Avg Shares Out | 2.11B | 2.11B | 2.11B | 2.11B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.00B | 1.74B | 1.74B | 1.74B |
| Weighted Avg Shares Out (Dil) | 2.11B | 2.11B | 2.11B | 2.11B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.12B | 2.00B | 1.74B | 2.12B | 2.12B |
Alfa|SIGMA reports 3Q24 EBITDA of US $275 million, up 13% vs 3Q23, with Alpek as Discontinued Operations
Shareholders approve the spin-off of ALFA's entire stake in Alpek
Source: https://incomestatements.info
Category: Stock Reports